A detailed history of Nea Management Company, LLC transactions in Senti Biosciences, Inc. stock. As of the latest transaction made, Nea Management Company, LLC holds 4,426,151 shares of SNTI stock, worth $9.65 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
4,426,151
Previous 4,426,151 -0.0%
Holding current value
$9.65 Million
Previous $1.68 Million 26.29%
% of portfolio
0.12%
Previous 0.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$0.6 - $1.14 $164,540 - $312,626
-274,234 Reduced 5.83%
4,426,151 $2.79 Million
Q1 2023

May 15, 2023

BUY
$1.15 - $2.06 $315,369 - $564,922
274,234 Added 6.2%
4,700,385 $5.55 Million
Q4 2022

Feb 10, 2023

SELL
$1.25 - $65.2 $4,467 - $233,024
-3,574 Reduced 0.08%
4,426,151 $6.24 Million
Q2 2022

Aug 15, 2022

BUY
$1.97 - $10.0 $8.73 Million - $44.3 Million
4,429,725 New
4,429,725 $7.46 Million

Others Institutions Holding SNTI

About Senti Biosciences, Inc.


  • Ticker SNTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,757,100
  • Market Cap $95.4M
  • Description
  • Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antig...
More about SNTI
Track This Portfolio

Track Nea Management Company, LLC Portfolio

Follow Nea Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nea Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nea Management Company, LLC with notifications on news.